Understanding Dupixent: Essential Information for Patients with Nasal Polyps

Understanding Nasal Polyps and Their Impact

Nasal polyps are noncancerous, teardrop-shaped growths that form on the lining of the nasal passages and sinuses. These growths result from chronic inflammation and can be associated with asthma, recurrent infection, allergies, drug sensitivity, or certain immune disorders. Nasal polyps can cause symptoms such as runny nose, persistent stuffiness, reduced sense of smell, and headaches. For many, they represent a significant disruption to daily life.

According to recent data, approximately 4% of the US adult population suffers from nasal polyps. This condition typically affects adults and is rare in children. It often leads to significant patient discomfort, impacting sleep quality, daily activities, and overall wellbeing.

What is Dupixent?

Dupixent (dupilumab) is a biologic medication first approved by the FDA in 2017 for treating moderate-to-severe eczema. Over the years, its approved uses have expanded to include other conditions, demonstrating its efficacy and versatility. Notably, in 2019, Dupixent received FDA approval for the treatment of adults with chronic rhinosinusitis with nasal polyps (CRSwNP), offering hope to those for whom conventional treatments have been ineffective.

How Dupixent Works

Dupixent works by targeting a specific protein in the body involved in inflammation, known as interleukin-4 (IL-4). By blocking the signaling of IL-4 and IL-13, Dupixent helps reduce inflammation in conditions such as eczema, asthma, and CRSwNP, thereby easing symptoms and improving quality of life.

Benefits of Dupixent for Nasal Polyps

For patients with CRSwNP, Dupixent offers several benefits:

• Reduction in polyp size: Clinical trials have shown that Dupixent effectively shrinks nasal polyps, reducing congestion and improving breathing.
• Improved sense of smell: Many patients experience a significant improvement in their ability to smell, which can greatly enhance quality of life.
• Fewer systemic corticosteroids: Dupixent usage can often eliminate or reduce the need for oral corticosteroids, which can have severe side effects.
• Reduced need for surgery: By controlling symptoms effectively, Dupixent can decrease the need for repeated surgical interventions in chronic cases.

A study published in 2026 found that around 75% of patients on Dupixent experienced a significant reduction in nasal congestion and improved nasal airflow after 24 weeks of treatment.

Eligibility and Considerations

Who Should Consider Dupixent?

Dupixent is typically recommended for adults with moderate-to-severe CRSwNP whose symptoms are inadequately controlled with intranasal corticosteroids. It is most beneficial for individuals who have had limited success with other treatments, including surgery.

Potential Side Effects

As with any medication, Dupixent may have side effects. Common side effects include:

• Injection site reactions
• Eye and eyelid inflammation
• Oral herpes
• Joint aches

Most side effects are mild to moderate. However, any concerns should be promptly discussed with a healthcare provider.

The Cost of Dupixent

In the US, the cost of Dupixent can be substantial, often amounting to several thousand dollars per year. Fortunately, many insurance plans offer coverage for Dupixent, especially if it is deemed medically necessary. Patients are encouraged to verify coverage and explore patient assistance programs offered by the manufacturer, Regeneron Pharmaceuticals, to help manage expenses.

Real-World Experiences

Patient testimonials highlight the transformative power of Dupixent. One patient, John from Texas, reported a dramatic improvement in his daily life after years of battling with nasal congestion and routine surgeries. Similarly, a recent online patient survey conducted in 2026 revealed a satisfaction rate of 82% among Dupixent users in managing nasal polyps.

Conclusion

For individuals suffering from chronic rhinosinusitis with nasal polyps, Dupixent offers a promising treatment option. The decision to start Dupixent should always involve a discussion with a healthcare professional to thoroughly assess potential benefits and risks. With continued advancements and research in biologic therapies, Dupixent stands at the forefront of improving the quality of life for patients struggling with this challenging condition.

To learn more about Dupixent and its uses, patients and healthcare providers can visit the official site of the FDA or consult resources provided by the American Academy of Otolaryngology.